MRI in rectal cancer: An institutional real life analysis of technical parameters
DISCUSSION: In an era of increasing individualized patient care and conservative treatment focused on tumour response and prognostic factors, the present study showed that compliance to MRI protocols and reporting guidelines needs improving to upgrade patient care.PMID:37858424 | DOI:10.1016/j.bulcan.2023.08.010 (Source: Bulletin du Cancer)
Source: Bulletin du Cancer - October 20, 2023 Category: Cancer & Oncology Authors: Alexandre Mayaud R émi Grange Bertrand Leroy Jean-Marc Phelip Sandrine Sotton Claire Boutet Nicolas Magn é Source Type: research
Introduction to spatial omics
Bull Cancer. 2023 Oct 17:S0007-4551(23)00384-3. doi: 10.1016/j.bulcan.2023.09.005. Online ahead of print.NO ABSTRACTPMID:37858425 | DOI:10.1016/j.bulcan.2023.09.005 (Source: Bulletin du Cancer)
Source: Bulletin du Cancer - October 20, 2023 Category: Cancer & Oncology Authors: Nathalie M Mazure Source Type: research
HER2 epidermal growth factor receptor, tests used to look for its amplification in breast cancer: Principles and limitations
This article summarises the different techniques used to determine HER2 status and provides a detailed review of the literature on pre-analytical factors and intrinsic tumour-specific factors that can distort or complicate the interpretation of results.PMID:37858426 | DOI:10.1016/j.bulcan.2023.08.012 (Source: Bulletin du Cancer)
Source: Bulletin du Cancer - October 20, 2023 Category: Cancer & Oncology Authors: Imane Eliahiai Mohammed Eljiar Sanae Chaib Jinane KHarmoum Mariame Chra ïbi Source Type: research
Photobiomodulation in the prevention and the management of side effects of cancer treatments: Bases, results and perspectives
CONCLUSION: Published data suggest that PBM could therefore be considered as supportive care in its own right for patients treated with radiation, chemotherapy, immunotherapy, hormone therapy or targeted therapies, whether in clinical practice or clinical trials. therapies. However, until solid data have been published on its long-term safety, the use of PBM should be considered with caution and within the recommended parameters and doses, particularly when practiced in areas of known or possible tumours. In this case, the patient should be informed of the theoretical benefits and risks of PBM in order to obtain informed c...
Source: Bulletin du Cancer - October 20, 2023 Category: Cancer & Oncology Authors: Kamel Lairedj Guillaume Klausner Julien Robijns Praveen R Arany Ren é-Jean Bensadoun Source Type: research
Trends in the frequency of cancer in France
We present and discuss recent data on the frequency of cancer in France. In the male population, the incidence of cancer has been stable since 2010 and mortality is decreasing; changes in the incidence of all cancers are dominated by changes in the incidence of prostate cancer, which is highly dependent on the extent of screening. In the female population, cancer incidence is rising and mortality is falling; the increase in the incidence of all cancers is partly due to the rise in the incidence of lung cancer, a consequence of women taking up smoking in the early 1970s.PMID:37858423 | DOI:10.1016/j.bulcan.2023.09.007 (Sour...
Source: Bulletin du Cancer - October 20, 2023 Category: Cancer & Oncology Authors: Catherine Hill Source Type: research
MRI in rectal cancer: An institutional real life analysis of technical parameters
DISCUSSION: In an era of increasing individualized patient care and conservative treatment focused on tumour response and prognostic factors, the present study showed that compliance to MRI protocols and reporting guidelines needs improving to upgrade patient care.PMID:37858424 | DOI:10.1016/j.bulcan.2023.08.010 (Source: Bulletin du Cancer)
Source: Bulletin du Cancer - October 20, 2023 Category: Cancer & Oncology Authors: Alexandre Mayaud R émi Grange Bertrand Leroy Jean-Marc Phelip Sandrine Sotton Claire Boutet Nicolas Magn é Source Type: research
Introduction to spatial omics
Bull Cancer. 2023 Oct 17:S0007-4551(23)00384-3. doi: 10.1016/j.bulcan.2023.09.005. Online ahead of print.NO ABSTRACTPMID:37858425 | DOI:10.1016/j.bulcan.2023.09.005 (Source: Bulletin du Cancer)
Source: Bulletin du Cancer - October 20, 2023 Category: Cancer & Oncology Authors: Nathalie M Mazure Source Type: research
HER2 epidermal growth factor receptor, tests used to look for its amplification in breast cancer: Principles and limitations
This article summarises the different techniques used to determine HER2 status and provides a detailed review of the literature on pre-analytical factors and intrinsic tumour-specific factors that can distort or complicate the interpretation of results.PMID:37858426 | DOI:10.1016/j.bulcan.2023.08.012 (Source: Bulletin du Cancer)
Source: Bulletin du Cancer - October 20, 2023 Category: Cancer & Oncology Authors: Imane Eliahiai Mohammed Eljiar Sanae Chaib Jinane KHarmoum Mariame Chra ïbi Source Type: research
Photobiomodulation in the prevention and the management of side effects of cancer treatments: Bases, results and perspectives
CONCLUSION: Published data suggest that PBM could therefore be considered as supportive care in its own right for patients treated with radiation, chemotherapy, immunotherapy, hormone therapy or targeted therapies, whether in clinical practice or clinical trials. therapies. However, until solid data have been published on its long-term safety, the use of PBM should be considered with caution and within the recommended parameters and doses, particularly when practiced in areas of known or possible tumours. In this case, the patient should be informed of the theoretical benefits and risks of PBM in order to obtain informed c...
Source: Bulletin du Cancer - October 20, 2023 Category: Cancer & Oncology Authors: Kamel Lairedj Guillaume Klausner Julien Robijns Praveen R Arany Ren é-Jean Bensadoun Source Type: research
Trends in the frequency of cancer in France
We present and discuss recent data on the frequency of cancer in France. In the male population, the incidence of cancer has been stable since 2010 and mortality is decreasing; changes in the incidence of all cancers are dominated by changes in the incidence of prostate cancer, which is highly dependent on the extent of screening. In the female population, cancer incidence is rising and mortality is falling; the increase in the incidence of all cancers is partly due to the rise in the incidence of lung cancer, a consequence of women taking up smoking in the early 1970s.PMID:37858423 | DOI:10.1016/j.bulcan.2023.09.007 (Sour...
Source: Bulletin du Cancer - October 20, 2023 Category: Cancer & Oncology Authors: Catherine Hill Source Type: research
MRI in rectal cancer: An institutional real life analysis of technical parameters
DISCUSSION: In an era of increasing individualized patient care and conservative treatment focused on tumour response and prognostic factors, the present study showed that compliance to MRI protocols and reporting guidelines needs improving to upgrade patient care.PMID:37858424 | DOI:10.1016/j.bulcan.2023.08.010 (Source: Bulletin du Cancer)
Source: Bulletin du Cancer - October 20, 2023 Category: Cancer & Oncology Authors: Alexandre Mayaud R émi Grange Bertrand Leroy Jean-Marc Phelip Sandrine Sotton Claire Boutet Nicolas Magn é Source Type: research
Introduction to spatial omics
Bull Cancer. 2023 Oct 17:S0007-4551(23)00384-3. doi: 10.1016/j.bulcan.2023.09.005. Online ahead of print.NO ABSTRACTPMID:37858425 | DOI:10.1016/j.bulcan.2023.09.005 (Source: Bulletin du Cancer)
Source: Bulletin du Cancer - October 20, 2023 Category: Cancer & Oncology Authors: Nathalie M Mazure Source Type: research
HER2 epidermal growth factor receptor, tests used to look for its amplification in breast cancer: Principles and limitations
This article summarises the different techniques used to determine HER2 status and provides a detailed review of the literature on pre-analytical factors and intrinsic tumour-specific factors that can distort or complicate the interpretation of results.PMID:37858426 | DOI:10.1016/j.bulcan.2023.08.012 (Source: Bulletin du Cancer)
Source: Bulletin du Cancer - October 20, 2023 Category: Cancer & Oncology Authors: Imane Eliahiai Mohammed Eljiar Sanae Chaib Jinane KHarmoum Mariame Chra ïbi Source Type: research
Photobiomodulation in the prevention and the management of side effects of cancer treatments: Bases, results and perspectives
CONCLUSION: Published data suggest that PBM could therefore be considered as supportive care in its own right for patients treated with radiation, chemotherapy, immunotherapy, hormone therapy or targeted therapies, whether in clinical practice or clinical trials. therapies. However, until solid data have been published on its long-term safety, the use of PBM should be considered with caution and within the recommended parameters and doses, particularly when practiced in areas of known or possible tumours. In this case, the patient should be informed of the theoretical benefits and risks of PBM in order to obtain informed c...
Source: Bulletin du Cancer - October 20, 2023 Category: Cancer & Oncology Authors: Kamel Lairedj Guillaume Klausner Julien Robijns Praveen R Arany Ren é-Jean Bensadoun Source Type: research
V éronique Trillet-Lenoir
Bull Cancer. 2023 Oct 16:S0007-4551(23)00382-X. doi: 10.1016/j.bulcan.2023.09.003. Online ahead of print.NO ABSTRACTPMID:37852800 | DOI:10.1016/j.bulcan.2023.09.003 (Source: Bulletin du Cancer)
Source: Bulletin du Cancer - October 18, 2023 Category: Cancer & Oncology Authors: Gilles Freyer Source Type: research
